References

Targeting sepsis: Disease tolerance, immune resilience, and compartmentalized immunity

10.3390/biomedicines12112420 · 2024 · External reference

Severe COVID-19 and sepsis: Immune pathogenesis and laboratory markers

10.3390/microorganisms9010159 · 2021 · External reference

Advances in mechanisms of systemic lupus erythematosus

2014 · External reference

Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications

10.1016/j.jfma.2021.03.019 · 2021 · External reference

Immunosenescence: A critical factor associated with organ injury after sepsis

10.3389/fimmu.2022.917293 · 2022 · External reference

An update on pathogenesis of systemic lupus erythematosus

2014 · External reference

Clinical and immunological biomarkers for systemic lupus erythematosus

10.3390/biom11070928 · 2021 · External reference

RIPK1/RIPK3/MLKL necrosome contributes to the sepsis-induced cardiorenal necroptotic inflammatory injury and mortality

10.2174/0118761429374574250415114715 · 2024 · External reference

Stimulation of soluble guanylyl cyclase (sGC) by cinaciguat attenuates sepsisinduced cardiac injury

10.2174/0118761429387280250506114040 · 2024 · External reference

Oral hydroxychloroquine mitigates lipopolysaccharide-induced lung injury by inhibiting pyroptosis in mice

10.2174/1874467215666220822110855 · 2023 · External reference

Mendelian randomization and infection: Pitfalls and promises

10.1093/infdis/jiaf251 · 2025 · External reference

Investigation of genes associated with atherosclerosis in patients with systemic lupus erythematosus

10.46497/archrheumatol.2021.8024 · 2021 · External reference

Endogenous retroviruses transcriptional modulation after severe infection, trauma and burn

10.3389/fimmu.2018.03091 · 2018 · External reference

Limma powers differential expression analyses for RNA-sequencing and microarray studies

10.1093/nar/gkv007 · 2015 · External reference

The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest

10.1093/nar/gkac1000 · 2023 · External reference

KEGG for taxonomy-based analysis of pathways and genomes

10.1093/nar/gkac963 · 2023 · External reference

KEGG: Kyoto encyclopedia of genes and genomes

10.1093/nar/28.1.27 · 2000 · External reference

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

10.1038/s41467-019-09234-6 · 2019 · External reference

KEGG: Kyoto encyclopedia of genes and genomes

10.1093/nar/27.1.29 · 1999 · External reference

A novel immune-related gene signature to identify the tumor microenvironment and prognose disease among patients with oral squamous cell carcinoma patients using ssGSEA: A bioinformatics and biological validation study

10.3389/fimmu.2022.922195 · 2022 · External reference

Genomic atlas of the human plasma proteome

10.1038/s41586-018-0175-2 · 2018 · External reference

pROC: An open-source package for R and S+ to analyze and compare ROC curves

10.1186/1471-2105-12-77 · 2011 · External reference

Combining machine learning and single-cell sequencing to identify key immune genes in sepsis

10.1038/s41598-025-85799-1 · 2025 · External reference

Modulation of the itaconate pathway attenuates murine lupus

10.1002/art.42284 · 2022 · External reference

4-Octyl-itaconate and dimethyl fumarate inhibit COX2 expression and prostaglandin production in macrophages

10.4049/jimmunol.2100488 · 2021 · External reference

Dataset on the differentiation of THP-1 monocytes to LPS inducible adherent macrophages and their capacity for NO/iNOS signaling

10.1016/j.dib.2021.106786 · 2021 · External reference

4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects

10.1038/s41467-019-13078-5 · 2019 · External reference

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease

10.3389/fmed.2022.979373 · 2022 · External reference

SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies

10.1136/rmdopen-2021-001934 · 2022 · External reference

CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity

10.1007/s15010-021-01606-9 · 2021 · External reference

SIGLEC1 (CD169): A marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients

10.1038/s41598-021-89786-0 · 2021 · External reference

Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway

10.1007/s00210-024-03456-2 · 2024 · External reference

Crystal structure of the TRIM25 B30.2 (PRYSPRY) domain: A key component of antiviral signalling

10.1042/bj20121425 · 2013 · External reference

TRIM25 and DEAD-Box RNA helicase DDX3X cooperate to regulate RIG-I-mediated antiviral immunity

10.3390/ijms22169094 · 2021 · External reference

The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases

10.1016/j.bbcan.2023.188954 · 2023 · External reference

TRIM25 dictates selective miRNA loading into extracellular vesicles during inflammation

10.1038/s41598-023-50336-5 · 2023 · External reference

TRIM25 inhibits HBV replication by promoting HBx degradation and the RIG-I-mediated pgRNA recognition

10.1097/cm9.0000000000002617 · 2023 · External reference

TRIMmunity: The roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity

10.1016/j.jmb.2013.12.005 · 2014 · External reference

TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway

10.1038/s41467-019-14190-2 · 2020 · External reference